Translate
Genprex Inc
About
Genprex Inc (NASDAQ:GNPX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
Apr 22 2026
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting
Apr 21 2026
Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy
Apr 20 2026
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Mar 18 2026
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Recent Videos
The Future of Medicine Is Code — Not Chemistry 🔬
Apr 04, 2026
From the Clinic to the Stock Market: The Genprex Story 💉
Apr 03, 2026
Can a Single Gene Change Everything? The Science Behind Genprex 🔬
Apr 02, 2026
Rewriting Disease: Gene Therapy for Lung Cancer & Diabetes 🧬
Apr 01, 2026
Financials
Revenue
$0
Market Cap
$3.36 M
EPS
-17.40